An observational, real world evidence study to describe clinical experience with lurasidone in the treatment of adult patients with schizophrenia in routine clinical
practice in Europe (LATUDA)

First published 22/03/2019

Last updated 14/03/2024

EU PAS number:

EUPAS28735

Study

Finalised

Documents

Study protocol

Initial protocol

PT-SUNOVION LATUDA Study Protocol V3 0 20SEP18 FINAL

English (885.02 KB - PDF)View document

Updated protocol

PT_Sunovion LATUDA_v4 0_25OCT19_clean

First published: 22/02/2024

English (504.4 KB - PDF)View document

Study results

CSR_Sunovion LATUDA_v1 0_FINAL

English (701.75 KB - PDF)View document

Study report

Other information

Study, other information

18 LO 1591 250852 Favourable_opinion_12.10.18

English (256.47 KB - PDF)View document

Secondary tabs